Generic Name : INSULIN GLARGINE ABSTRACT – Basaglar is an insulin injection that works evenly over 24 hours against...
Basaglar
Insulin glargine, marketed under the names Lantus among others, is a long-acting insulin, used in the treatment of type I and type II diabetes. Basaglar is not typically the recommended long acting insulin in the United Kingdom. Basaglar is used once a day as an injection just under the skin. Effects generally begin an hour after use.
Common side effects include low blood sugar, problems at the site of injection, itchiness, and weight gain. Other serious side effects include low blood potassium. NPH insulin rather than insulin glargine is generally preferred in pregnancy.After injection microcrystals slowly release insulin for about 24 hours.This insulin causes body tissues to absorb glucose from the blood and decreases glucose production by the liver.
Insulin glargine was approved for medical use in the United States in 2000.In the United States the wholesale cost per 100 units is about 26 USD as of 2018. In the United Kingdom this amount costs the NHS about £2.35.In 2016 it was the 22nd most prescribed medication in the United States with more than 26 million prescriptions
. Designed by